Sanofi stock gains on Cheplapharm deal and Buy call
Published on 09/17/2026 at 14:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sanofi stock (ISIN FR0000127771) closed at EUR 74.59 on September 16, 2026, up 0.45 percent from the prior close of EUR 74.25. The move came after Sanofi said on September 14, 2026, that it had agreed a portfolio transfer with Cheplapharm, while Deutsche Bank kept its Buy rating and EUR 95 price target on September 15, 2026.
Deal and rating stay in view
According to Bolsamania, Sanofi agreed to transfer a portfolio of 20 mature medicines, including enoxaparin products, plus three manufacturing sites in Hungary, Singapore and France in exchange for a 26.4 percent stake in Cheplapharm. The same report said the transaction is not expected to affect Sanofi's 2026 financial guidance.
According to finanzen.at, Deutsche Bank Research left Sanofi at Buy with a EUR 95 price target on September 15, 2026. The portal also showed a reference price of EUR 74.59 and an implied gap of 27.36 percent to the target.
Price still below target
On September 16, 2026, the Sanofi stock price of EUR 74.59 sat 21.94 percent below the EUR 95 Deutsche Bank target. The 52-week range was EUR 42.59 to EUR 77.25, so the close sat close to the top of that band.
What the market watches
For investors, the key point is the mix of asset rotation and valuation. The stock reacted to a deal that Sanofi said will not hit 2026 guidance, while UBS also stayed Neutral on September 17, 2026, according to Zonebourse.
Sanofi stock facts
- Company: Sanofi S.A.
- ISIN: FR0000127771
- Ticker: SAN
- Trading venue: Euronext Paris
- Price (as of September 16, 2026): EUR 74.59
- Market capitalization: EUR 92.8 billion (as of September 16, 2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: CAC 40
Sanofi stock holds its range
Sanofi stock closed at EUR 74.59 on September 16, 2026, with volume and the current market value keeping it inside a EUR 42.59 to EUR 77.25 yearly band. More news and analyses on Sanofi stock can be found at the internal topic page.
